http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-6824481-B1

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-322
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165
filingDate 2019-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-6824481-B1
titleOfInvention Composition for prevention and treatment of spinal cord injury
abstract PROBLEM TO BE SOLVED: To provide a pharmaceutical composition for preventing or treating spinal cord injury. SOLUTION: The present invention is characterized by containing (S) -2-(((4'-trifluoromethylbiphenyl-4-yl) methyl) amino) propanamide methanesulfonate or a pharmaceutically acceptable salt thereof as an active ingredient. And provided as a pharmaceutical composition for the prevention or treatment of spinal cord injury. [Selection diagram] Fig. 2a
priorityDate 2018-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492924
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449012232
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554068
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527139
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6035
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3424274
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21891451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410574311
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483142
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474470
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526595
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3821
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID124604970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7083
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322421
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535430
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14982
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6578
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID132229257
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448075387
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439239
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6741

Total number of triples: 41.